Christian Pradier

Author PubWeight™ 84.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003 12.23
2 Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 2006 9.21
3 Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet 2008 8.73
4 Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study. AIDS 2003 5.61
5 Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS 2010 3.47
6 HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS 2008 2.27
7 Factors associated with adherence to infectious diseases advice in two intensive care units. J Antimicrob Chemother 2006 2.04
8 Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy. Ann Intern Med 2002 1.70
9 Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002. Arch Intern Med 2006 1.69
10 Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients. AIDS 2004 1.64
11 Kaposi's sarcoma in transplant and HIV-infected patients: an epidemiologic study in Italy and France. Transplantation 2005 1.52
12 Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer 2007 1.40
13 Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS 2003 1.27
14 Influence of child care on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae. Pediatr Infect Dis J 2003 1.14
15 Impact of late presentation on the risk of death among HIV-infected people in France (2003-2009). J Acquir Immune Defic Syndr 2013 1.14
16 Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains. J Antimicrob Chemother 2014 1.06
17 Haemophilus influenzae carriage in children attending French day care centers: a molecular epidemiological study. J Clin Microbiol 2003 1.05
18 Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders? AIDS 2014 0.99
19 Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease events. AIDS 2013 0.98
20 Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4). Int J Epidemiol 2014 0.96
21 Trends in nasopharyngeal carriage of Streptococcus pneumoniae among children attending daycare centers in southeastern France from 1999 to 2006. Pediatr Infect Dis J 2008 0.95
22 Associations between immune depression and cardiovascular events in HIV infection. AIDS 2013 0.94
23 Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study. Diabetes Care 2008 0.94
24 Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort. Clin Infect Dis 2013 0.91
25 Etanercept compared to intraarticular corticosteroid injection in rheumatoid arthritis: double-blind, randomized pilot study. J Rheumatol 2011 0.87
26 Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort. AIDS 2014 0.87
27 The 2008-2012 French Alzheimer plan: description of the national Alzheimer information system. J Alzheimers Dis 2012 0.86
28 Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study. J Acquir Immune Defic Syndr 2015 0.86
29 Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients. PLoS One 2013 0.85
30 First-line highly active antiretroviral regimens in 2001-2002 in the French Hospital Database on HIV: combination prescribed and biological outcomes. Antivir Ther 2007 0.85
31 Impact of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae among children attending group daycare in southeastern France. Pediatr Infect Dis J 2015 0.85
32 HCV/HIV co-infection, HCV viral load and mode of delivery: risk factors for mother-to-child transmission of hepatitis C virus? AIDS 2007 0.84
33 IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy--results from the ANRS CO4 cohort. J Antimicrob Chemother 2010 0.84
34 Lopinavir/ritonavir combination and total/HDL cholesterol ratio. J Infect 2005 0.84
35 [Emergencies in patients undergoing palliative care at home. A qualitative study of telephone calls to Center 15]. Presse Med 2002 0.83
36 The French National Alzheimer database: a fast growing database for researchers and clinicians. Dement Geriatr Cogn Disord 2014 0.83
37 [Impact of a hospice home visit team on unwanted hospitalization of terminally-ill patients at home in acute medical emergencies]. Presse Med 2007 0.82
38 Antibiotic prescriptions in French day-care centres: 1999-2008. Arch Dis Child 2011 0.81
39 Investigating the completeness of a histopathological cancer registry: estimation by capture-recapture analysis in a French geographical unit Alpes-Maritimes, 2008. Cancer Epidemiol 2011 0.81
40 Determinants and changes associated with aldosterone breakthrough after angiotensin II receptor blockade in patients with type 2 diabetes with overt nephropathy. Clin J Am Soc Nephrol 2013 0.81
41 Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer). Pharmacoepidemiol Drug Saf 2012 0.80
42 Baseline CD4 cell count and outcome of pegylated interferon plus ribavirin therapy in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 2008 0.79
43 Effects of Increasing Hydrocortisone to 300 mg Per Day in the Treatment of Septic Shock: a Pilot Study. Shock 2016 0.79
44 Association between ALT level and the rate of cardio/cerebrovascular events in HIV-positive individuals: the D: A: D study. J Acquir Immune Defic Syndr 2013 0.79
45 Development and validation of the aging stereotypes and exercise scale. J Aging Phys Act 2012 0.79
46 Incidence of inflammatory bowel disease in Corsica from 2002 to 2003. Gastroenterol Clin Biol 2007 0.79
47 Relevance of lipopolysaccharide levels in HIV-associated neurocognitive impairment: the Neuradapt study. J Neurovirol 2013 0.78
48 Impact of newly available drugs on clinical progression in patients with virological failure after exposure to three classes of antiretrovirals. Antivir Ther 2005 0.78
49 [Adapting the environment to encourage the elderly to walk: a qualitative study]. Sante Publique 2011 0.77
50 ["Antibiotics only when necessary" campaign in the Alpes-Maritimes district: no negative impact on invasive infections in children in the community 1998-2003]. Presse Med 2008 0.77
51 Mild cognitive impairment and anti-Alzheimer disease medications: A cross sectional study of the French National Alzheimer Databank (BNA). J Alzheimers Dis 2014 0.77
52 Obstetric management does not influence vertical transmission of HCV infection: results of the ALHICE group study. J Matern Fetal Neonatal Med 2013 0.76
53 [How to raise awareness about antibiotics and vaccination among French teenagers?] Sante Publique 2017 0.75
54 What do HIV-infected patients become after an opportunistic infection? AIDS 2006 0.75
55 [Data quality of cancer registration by Adicap codes, used by French pathologists from Paca, 2005-2006]. Ann Pathol 2009 0.75
56 Is Inappropriate Response to Cosyntropin Stimulation Test an Indication of Corticosteroid Resistance in Septic Shock? Shock 2017 0.75
57 [Promoting primary care screening for Chlamydia trachomatis infection]. Sante Publique 2016 0.75
58 Impact of Different Surgical Techniques on Outcomes in Laparoscopic Sleeve Gastrectomies: First Report from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP). Ann Surg 2017 0.75
59 [Registry of liver biopsies from hepatitis C infected patients in the Alpes-Maritimes (France). Results from the first 2 years]. Gastroenterol Clin Biol 2002 0.75
60 Interleukine-2 therapy does not increase the risk of Hodgkin or non-Hodgkin lymphoma in HIV-infected patients: results from FHDH ANRS CO4. J Acquir Immune Defic Syndr 2009 0.75
61 [Peer visits to community-based general practitioners and pediatricians as part of the "Antibiotics only when necessary" campaign in the Alpes-Maritimes district. Methodology, feasibility, and interest]. Presse Med 2006 0.75
62 [Focusing on the steps to follow to initiate a clinical research project]. Nephrol Ther 2011 0.75
63 [Innovating for an EHPAD of the future: the suggestions of professionals in the Alpes-Maritimes (France)]. Sante Publique 2011 0.75